SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference 2023 ... New Technologies Device Project Leader, Novartis Amber Witteman, Founder, Managing Director ...

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

It is playing catch-up with a rival Lp(a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...

“The Novartis collaboration presents an extraordinary opportunity to leverage our unbiased genetic screening platform and proprietary chemical libraries to address novel, high-value targets previously ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

A suspicious package being mailed to Juneau was intercepted Jan. 1 by Southeast Cites Against Drugs (SEACAD), according to a JPD information release published Wednesday. “During the ...

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and injunctions. Vandana Singh Your Healthcare Costs are Soaring! US Spending Reached ...

The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...

We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Maintaining independence and editorial freedom is essential to ...

We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Maintaining independence and editorial freedom is essential to ...